AI assistant
InspireMD, Inc. — Director's Dealing 2021
Feb 10, 2021
34187_dirs_2021-02-10_c738c0ab-28d4-4541-ba71-bab97693e8da.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2021-02-08
Reporting Person: Slosman Marvin (Director, CEO and President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-08 | Common Stock | P | 40320 | $0.62 | Acquired | 1453538 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-08 | Warrants | $0.682 | P | 20160 | Acquired | 2026-02-08 | Common stock (20160) | Direct |
| 2020-08-31 | Options (right to buy) | $0.39 | A | 391762 | Acquired | 2030-08-31 | Common stock (391762) | Direct |
Footnotes
F1: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 40,320 shares of common stock and warrants to purchase 20,160 shares of common stock together, as part of 40,320 units, at a purchase price of $0.62 per unit.
F2: The Reporting Person has not engaged in any reportable transactions with respect to these derivative securities of the Issuer and is including his ownership of these securities for informational purposes only in this Form 4.
F3: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.